A-share pharmaceutical sector: falling for a long time will rise, **storm is coming?
In recent years, whether it is the US stock market or the A-share market, the pharmaceutical sector has experienced a long and painful **.
The U.S. pharmaceutical sector has fallen by a staggering 70% from its high**, leaving countless investors heartbroken.
However, recently, American pharmaceutical companies have staged a good show of Jedi counterattack, directly **50%.
At the same time, the pharmaceutical sector of A-shares is still lying on the ground, as if it has been forgotten.
History is always strikingly similar. The strength of the U.S. pharmaceutical sector has undoubtedly brought hope and inspiration to the A-share pharmaceutical sector.
After all, there will always be a time when it rises after falling for a long time, which is the unchanging truth. Plus China's ** bull market is coming.
So, can the A-share pharmaceutical sector also usher in a wave of strength?
In my opinion, the probability is very high!
First of all, from the perspective of industry fundamentals, the pharmaceutical industry is a long-term growth industry, with the aging of the population and the increase in health demand, the prospects of the pharmaceutical market are still broad.
Secondly, from the policy level, the state's support for the pharmaceutical industry continues to increase, and innovative drugs, generic drugs and other fields will usher in development opportunities.
Finally, from a technical point of view, the A-share pharmaceutical sector has undergone a long period of adjustment, technical indicators have been oversold, and the demand for ** is very strong.
Of course, it doesn't happen overnight and takes time and patience.
However, for those investors who have been paying attention to the pharmaceutical sector for a long time and have confidence in the pharmaceutical industry, now may be a good time to lay out. After all, opportunities are always reserved for those who are prepared.
In short, although the A-share pharmaceutical sector has experienced a long period of time, there is still hope for it. Let's wait and see, and look forward to a wave of strong ** in the pharmaceutical sector, which will bring rich returns to investors!
The A-share pharmaceutical sector covers many well-known companies, and the following are some of the representative companies in this sector:
Hengrui Pharmaceutical: a leading enterprise of chemical pharmaceuticals in China, and a leader in antineoplastic drugs, surgical drugs and contrast agents. As a pioneer in the research and development of innovative drugs in China, Hengrui Pharmaceutical has a high influence in the pharmaceutical industry.
WuXi AppTec: This is a leading global open capability and technology platform that provides a full range of services for pharmaceutical R&D. Through its unique "one-stop, all-round, and open" R&D model, WuXi AppTec helps pharmaceutical companies in the entire process from drug discovery to clinical development.
Yunnan Baiyao: As the first national brand of traditional Chinese medicine, Yunnan Baiyao has outstanding performance in the research and development, production and sales of self-made industrial products, as well as in the wholesale and retail business of pharmaceuticals. Its brand influence and market position are very important in the Chinese medicine industry.
Huadong Pharmaceutical: This is a large-scale pharmaceutical enterprise based on scientific research and development, which integrates the production and sales of various pharmaceutical raw materials, preparations, pharmaceutical intermediates, medical devices, chemical reagents, packaging materials and medical and health supplies.
Tonghua Dongbao: This is a large-scale national pharmaceutical manufacturer mainly engaged in the production of Chinese and Western patent medicines and biological products. Its products cover a number of ** fields, such as diabetes, cardiovascular and cerebrovascular diseases, etc.
These companies not only have an important position in the A-share pharmaceutical sector, but also play a positive role in promoting the development and innovation of the entire pharmaceutical industry. Please note that the above information is for reference only, investment is risky, and specific investment decisions need to be evaluated according to personal risk tolerance and investment objectives.
**10,000 Fans Incentive Plan